Cardiovascular risk

Novo Nordisk’s SELECT Trial Shows Semaglutide 2.4 mg Cuts Cardiovascular Risk in Overweight and Obese Adults

(IN BRIEF) Novo Nordisk, a global healthcare company, has reported the headline findings from the SELECT cardiovascular outcomes trial. This…

9 months ago

European Commission funded project YOUNG 50 aimed at preventing cardiovascular disease risk factors in people aged 50 launches in Luxembourg, Lithuania and Romania

(PRESS RELEASE) LUXEMBOURG, 29-Nov-2021 — /EuropaWire/ — Luxembourg Institute of Health (LIH), a public biomedical research organisation, has announced that…

2 years ago

European Society of Cardiology, Prof Scott Montgomery: Severe infections in adulthood are associated with a contemporaneously raised risk of cardiovascular disease

SOPHIA ANTIPOLIS, 07-Aug-2017 — /EuropaWire/ — Pneumonia or sepsis in adults that results in hospital admission is associated with a six-fold…

7 years ago